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ABSTRACT: The regulatory spine is a set of conserved residues that are assembled and disassembled upon
activation and inactivation of kinases. We recently identified the regulatory spine within the immunologically
important Tec family kinases and have shown that in addition to the core spine residues within the kinase
domain itself, contributions from the SH2-kinase linker region result in an extended spine structure for this
kinase family. Disruption of the regulatory spine, either by mutation or by removal of the amino-terminal
SH2-kinase linker region or bymutation of core spine residues, leads to inactivation of the Tec kinases.With
a focus on the Tec familymembers, Itk andBtk, we now show that the gatekeeper residue is also critical for the
assembly of the regulatory spine. Mutation of the bulky Itk F434 gatekeeper residue to alanine or glycine
inactivates Itk. The activity of the Itk F434Amutant can be recovered by a secondary site mutation within the
N-terminal lobe, specifically L432I. The Itk L432I mutation likely rescues the activity of the gatekeeper
F434A mutation by promoting the assembly of the regulatory spine. We also show that mutation of the Itk
and Btk gatekeeper residues to methionine is sufficient to activate the isolated kinase domains of Tec kinases
in the absence of the amino-terminal SH2-kinase linker. Thus, shifting the conformational equilibrium
between the assembled and disassembled states of the regulatory spine by changing the nature of the
gatekeeper residue is key to regulating the activity of Tec kinases.
Protein kinases are enzymes that control key processes in the
cell by catalyzing the transfer of a phosphate group from ATP to
the hydroxyl moiety of Ser/Thr or Tyr (1, 2). The Tec family
kinases (Itk,1 Btk, Tec, Txk, and Bmx) are nonreceptor tyrosine
kinases that are expressed predominantly in hematopoietic cells
and function downstream of important immune receptors (3-6).
The domain architecture of the Tec kinases is similar to that of
the Src family kinases; both kinase families are characterized by
the SH3-SH2-kinase domain arrangement (7). In addition, the
Tec kinases (with the exception ofTxk) also contain a PHdomain
at the amino terminus making the overall domain architecture
distinct from that of the Src kinases (7-10). While extensive
biochemical and structural analyses of full-length Src kinases
have provided a mechanistic understanding of how the catalytic
activity of this kinase family is regulated (11, 12), an under-
standing of Tec kinase regulation lags significantly behind in
large part because of the lack of a high-resolution structure for
any of the full-length Tec kinases.
Despite the relative dearth of structural information for the
Tec kinase family, biochemical analyses have shown that the
regulation of the Tec kinases differs considerably from that of Src
kinases (10). One of the most notable differences lies in the fact
that the isolated kinase domains of the Src family kinases are
active, while the isolated kinase domains of the Tec kinases are
catalytically inert (9, 10, 13). The catalytic activity of the
Src kinases is negatively controlled by the amino-terminal
domains (14, 15). In contrast, the catalytic activity of the Tec
kinases is positively dependent on the presence of the amino-
terminal regulatory domains, more specifically the 17-residue
linker region between the SH2 domain and the kinase do-
main (10). A conserved tryptophan residue (Itk W355) in the
linker between the SH2 and kinase domains of the Tec kinases,
along with a conserved methionine residue (Itk M410) within
helix C of the kinase domain, plays a critical role in stabilizing the
active state of Tec kinases (10, 16). Like other kinase families, the
activity of the Tec kinases is also positively regulated by
phosphorylation on a conserved tyrosine (Itk Y511 or Btk
Y551) within a large flexible loop within the kinase domain
called the activation loop (17).
Recently, a conserved structure called the “regulatory spine”
has been identified as a key component in controlling the activity
of kinases (18, 19). The regulatory spine consists of a set of
residues that span the three-dimensional structure of the kinase
domain from the carboxy-terminal lobe to the amino-terminal
lobe. The regulatory spine residues are organized into an
assembled structure in active kinases and are disrupted in inactive
kinases (18). We have previously identified the regulatory spine
residues within the Tec family kinases (20). In that work, we
demonstrated that, in addition to the core regulatory spine
residues present within the kinase domain itself, the Tec kinases
contain an extended regulatory spine that includes the conserved
tryptophan (Itk W355) from within the SH2-kinase linker and
the conserved methionine (Itk M410) on helix C of the kinase
domain.
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Mutation of the residues that constitute the extended regula-
tory spine in the context of full-length Itk results in a drastic
reduction in the activity of the kinase (20). Moreover, the
presence of the SH2-kinase linker is critical for the assembly
of a stable regulatory spine in Tec kinases. In fact, the crystal
structures of the isolated kinase domain of Itk (without the
SH2-kinase linker) in the “active” (Y511 phosphorylated) and
“inactive” (Y511 unphosphorylated) states are identical (8). In
both structures, the distance between the crucial ion pair (Itk
K390 and E405) is∼8 A˚, significantly greater than the distance of
3-4 A˚ that is typically observed in structures of the active states
of kinases. Thus, in the absence of the SH2-kinase linker, the
regulatory spine of Tec kinases fails to assemble despite activa-
tion loop phosphorylation (20). The extended regulatory spine
within Tec kinases therefore defines an allosteric mechanism by
which the regulatory SH2-kinase linker region impinges on the
kinase domain in a positive manner and stabilizes the active
conformation of the kinase domain.
In addition to the regulatory spine and noncatalytic regulatory
domains and/or regions, there are other features that modulate
the activity of kinases. These include the gatekeeper residue, a key
residuewithin the amino-terminal lobe of the kinase that controls
access to a deep pocket within the kinase domain. Structural
studies have shown that the gatekeeper residue lies at the edge of
the regulatory spine, and introduction of a bulky hydrophobic
residue such as isoleucine or methionine at the gatekeeper
position has been demonstrated to stabilize the regulatory spine
and activate Src, Abl, and EGFR kinases (21).
In this paper, we explore the interplay between the regulatory
spine and the gatekeeper residue in the Tec family kinases. The
data demonstrate that mutation of the Itk gatekeeper residue
F434 to alanine or glycine inactivates full-length Itk. In the
context of this result, we identify a secondary mutation that
activates the Itk F434A mutant. Introduction of a β-branched
hydrophobic residue at position 432 (L432I) rescues the activity
of the Itk F434A mutant. We suggest that the β-branched
isoleucine at position 432 potentially compensates for the loss
of hydrophobicity of the F434Amutation and rescues the activity
of Itk by promoting the assembly of the regulatory spine.
Furthermore, we show that the isolated kinase domains of Itk
and Btk can be activated (regulatory spine assembled) in the
absence of the amino-terminal regulatory domains by mutation
of the gatekeeper residue to methionine. Thus, the gatekeeper
residue and the regulatory spine are keymodulators of Tec kinase
activity.
EXPERIMENTAL PROCEDURES
Constructs. The baculoviral expression constructs for full-
length (mouse) Itk have been described previously (10). The
bacterial expression constructs for the Itk kinase domain have
been described elsewhere (22). The mouse wild-type Btk kinase
domain (residues 396-659) was amplified via polymerase chain
reaction (PCR) and cloned into the pET 28b (Novagen) vector to
create the His-tagged Btk kinase domain. All mutations were
introduced by using the site-directed mutagenesis (SDM) kit
(Stratagene). All constructs were verified by sequencing at the
Iowa State University DNA synthesis and sequencing facility.
Protein Expression and Purification. Baculoviral con-
structs were expressed and purified from Sf9 cells as described
previously (10). The bacterial expression constructs for the
His-tagged Itk or Btk kinase domains were expressed and
purified from ArcticExpress cells (Stratagene) as described pre-
viously (22). Briefly, the Itk or Btk kinase domains were
expressed in ArcticExpress bacteria at 12 C for 23 h. The cell
pellets were resuspended in lysis buffer [0.5 mg/mL lysozyme,
50mMKH2PO4 (pH 8.0), 150 mMNaCl, and 20mM imidazole]
and stored overnight at-80 C.The cell pellets were thawed after
the addition of 1 mM PMSF and 3000 units of DNase I (Sigma).
The lysate was spun at 14K for 1 h at 4 C. The supernatant was
incubated with nickel NTA resin (Qiagen). The resin was washed
with wash buffer [50 mM Hepes (pH 7.5), 150 mM NaCl, and
40 mM imidazole] and then eluted with elution buffer [50 mM
Hepes (pH 7.5), 150 mM NaCl, 250 mM imidazole, and 10%
glycerol]. The proteins were aliquoted, flash-frozen with liquid
nitrogen, and stored at -80 C.
Kinase Assays andWestern Blotting. In vitro kinase assays
were performed via incubation of the isolated kinase domain of
Itk or Btk in a kinase assay buffer [50 mM Hepes (pH 7.0),
10 mMMgCl2, 1 mMDTT, 1 mg/mL BSA, 1 mMPefabloc, and
200 μM ATP] at room temperature for 1 h. The samples were
boiled, separated by SDS-PAGE, andWestern blotted with the
anti-Btk phosphoY551 antibody (BD Biosciences), anti-FLAG
antibody (Sigma), or anti-His antibody (Upstate) as described
previously (23). The anti-Btk phosphoY551 antibody is also used
for detection of phosphorylation on Itk Y511. Kinetic param-
eters for the full-length wild-type and mutant Itk are derived
using radioactive assays that have been described previously (10).
Activity measurements of the pY551 level-normalized wild-
type and mutant Btk kinase domain were conducted via pre-
incubation of the Btk kinase domain with ATP at room
temperature for varying lengths of time (Btk wild type and
T474I, 45 min; Btk T474A, 90 min; Btk T474M, 30 s). The
autophosphorylated Btk kinases were subsequently tested for
activity using radioactive assays as described previously (10).
RESULTS
The Itk F434A Gatekeeper Mutation Inactivates Full-
Length Itk. There is ample precedence for the activation of
kinase activity by mutation of the gatekeeper residue to a bulky
hydrophobic residue (21). In all kinases, the gatekeeper residue is
located on the β5 strand at the edge of the regulatory spine within
the N-terminal lobe of kinases, and introduction of a large
hydrophobic side chain is thought to promote kinase activity
by favoring the active, assembled conformation of the regulatory
spine (21). Interestingly, alignment of the β5 strand of the Itk
kinase domain with other members of the Tec kinase family
shows that Itk is unique within the Tec family of kinases as its
gatekeeper residue is a phenylalanine instead of the threonine
that is present in other Tec kinases (Figure 1a). Thus, for wild-
type Itk, the gatekeeper residue (F434) is already large and
hydrophobic, and inspection of the available Itk structures
suggests that F434 is adjacent to the spine and therefore might
be expected to favor assembly of the regulatory spine (Figure 1b).
Given the bulky, hydrophobic nature of the Itk gatekeeper
residue, we first tested the prediction that mutation of the Itk
gatekeeper residue to a smaller alanine or glycine residue would
shift the conformational equilibrium to the disassembled state of
the regulatory spine and result in inactive Itk. Indeed, mutation
of the bulky Itk gatekeeper residue F434 in full-length Itk to
either alanine or glycine leads to a dramatic loss of activity
(Figure 1c and Table 1). The Itk F434A mutant reduces the
activity to that of the kinase inactive K390R mutant of Itk,
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whereas the Itk F434G mutant retains ∼25% of the wild-type
kinase activity (Figure 1c and Table 1). Thus, mutation of the Itk
gatekeeper residue to alanine or glycine inactivates full-length Itk
presumably by destabilizing the assembled conformation of the
regulatory spine.
The L432I Mutation Is a Second-Site Mutation That
Rescues the Activity of the Itk F434A Mutant. Gatekeeper
mutations for many kinases have been extensively examined in
the context of generating kinase variants that are sensitive to
modified ATP analogues (24, 25). In the context of that work, it
has been found that certain kinases lose their activity upon
mutation of the gatekeeper residue to alanine or glycine. Such
kinases are termed “intolerant” kinases, whereas the kinases that
retain activity uponmutation of the gatekeeper residue to alanine
or glycine are defined as “tolerant” kinases (26). Previous work
on intolerant kinases has shown that their loss of activity because
of the gatekeeper mutation can be rescued by a second-site
mutation at one of several specific locations within the amino-
terminal lobe of the kinase (26). These activating secondary
mutations always involve introduction of a β-branched amino
acid residue at sites that do not contain a β-branched residue in
the wild-type sequence and cluster to the β2, β3, and β5 strands of
the N-terminal kinase lobe (26). Because we have demonstrated
that Itk is an intolerant kinase (Figure 1c), we next set out to
rescue the activity of the Itk F434Amutant using this second-site
mutagenesis strategy.
Alignment of the β2, β3, and β5 strands of Itk with those of
other members of the Tec kinase family shows that within the
β3 strand of Itk, V387 and I389 are already β-branched amino
acids and hence are not candidates for a secondary mutation
(Figure 1a). The Itk β2 and β5 strands have four potential
sites for second-site mutations: L375, H377, C431, and L432
(Figures 1a and 2a). Each of these residues was thereforemutated
to a β-branched amino acid within the context of full-length Itk
F434A and tested for activity using a peptide substrate. Three of
the double mutants, C431V/F434A, L375V/F434A, and H377V/
F434A, do not exhibit significant activity (Figure 2b and
Table 1). However, the Itk L432I/F434A double mutant has
significant kinase activity when compared to full-lengthwild-type
Itk (Figure 2b and Table 1). We further characterized the Itk
L432I/F434A double mutant by measuring its kinetic param-
eters. As shown in Figure 2c-e, the kinetic parameters (Km and
kcat) for the full-length Itk L432I/F434A double mutant are
nearly identical to that of wild-type full-length Itk. Hence, the Itk
L432I mutation is a second-site mutation that rescues the activity
of the Itk F434A gatekeeper mutation.
Stabilization of the Assembled State of the Regulatory
SpineActivates TecKinases in theAbsence of theN-Terminal
Regulatory Domains. Previous studies have demonstrated
that kinases can be activated by the introduction of a bulky
hydrophobic residue such as isoleucine or methionine at the
gatekeeper position (21). In fact, the gatekeeper residue has been
FIGURE 1: Itk gatekeeper residue F434 promotes the assembled state of the regulatory spine. (a) Alignment of the β2, β3, and β5 strands of the
N-terminal lobe of the kinase domain of Tec kinases. The gatekeeper residue of Itk is a phenylalanine (F434); all other Tec kinases contain a
threonine at the gatekeeper position (indicated with an arrow). Asterisks above the sequences indicate targets for the second-site mutagenesis. (b)
The crystal structure of the isolated Itk kinase domain in the absence of the SH2-kinase linker (brown cartoon, ProteinDataBank entry 1SNX) is
shownwith the disassembled regulatory spine residues:M409 (gray sticks and spheres) andL420,H479, F500, andD539 (blue sticks and spheres).
The boxed region is expanded to show the Itk gatekeeper F434 (orange sticks and spheres), and helix C is labeled. The crucial ion pair (Itk K390
and E405) that is assembled in active kinase structures is shown as red sticks and is not labeled. All structures in this and other figures were
generated using PyMOL (33). (c) The gatekeeper residue of Itk (F434) wasmutated to either alanine or glycine in the context of full-length Itk and
tested for its in vitro kinase activity as described in Experimental Procedures. Mutation of F434 to alanine or glycine reduces the activity of full-
length Itk to almost that of the kinase inactive mutant (K390R) of full-length Itk.
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identified as a hot spot for oncogenic transformation of several
kinases (27). An activating T315I gatekeeper mutation within the
Abl kinase domain and a T790M gatekeeper mutation within
EGFR have been detected in chronic myeloid leukemia (CML)
patients and lung cancer patients, respectively (21, 28). Structural
analysis of the Src gatekeeper T341I mutant showed that the
gatekeeper residue lies at the tip of the hydrophobic spine.
Because mutation of the gatekeeper residue to isoleucine or
methionine stabilizes the hydrophobic spine in other kinase
families, we next tested whether an analogous mutation would
activate Itk andBtk (all Tec kinases containThr at the gatekeeper
position with the exception of Itk that contains Phe as the
gatekeeper residue). The Tec kinases pose an additional chal-
lenge; the isolated kinase domains exhibit very poor activity in the
absence of the amino-terminal regulatory region (9, 10). Our
previous work has demonstrated that the amino-terminal region
(in particular the SH2-kinase linker region preceding the kinase
domain) is required for assembly of the regulatory spine and
activation of kinase actvity (10). We therefore hypothesized that
mutation of the gatekeeper residue within Btk (and possibly Itk)
to isoleucine or methionine might not only activate these kinases
by preorganizing the regulatory spine but also overcome the
requirement for the positive regulatory N-terminal region.
The gatekeeper residues of both Itk (F434) and Btk (T474)
were mutated to either isoleucine or methionine in the context of
the isolated Itk or Btk kinase domains. In vitro kinase activity
measurements show that mutation of the Itk or Btk gatekeeper
residue tomethionine in the context of the isolated kinase domain
results in an increase in activity compared to that of wild-type Btk
or Itk, respectively (Figure 3a,b and Table 1). Interestingly,
mutation of the gatekeeper residue to an isoleucine does not
activate either the Btk or Itk kinase domains (Figure 3a,b and
Table 1). This is in contrast to the findings that Src kinases are
activated by mutation of the gatekeeper threonine to isoleu-
cine (21). The activating effect of the methionine mutation versus
the isoleucine mutation likely reflects the better accommodation
of themethionine side chain over the β-branched isoleucine in the
structure of Itk and Btk. Additionally, consistent with our earlier
results that show the inactivating effect of the Itk F434A
mutation (Figure 1c), mutation of the Btk gatekeeper residue
T474 to alanine also decreases the activity of Btk, albeit to a lesser
extent than that of Itk (Figure 3a andTable 1). TheCD spectra of
the wild-type Itk and Btk isolated kinase domains overlay well
with those of their respective gatekeeper mutants, suggesting that
the observed changes in activity reflect the effect of mutation and
are not due to misfolding in the kinase domain (Figure S1a,b of
the Supporting Information). Overall, these results suggest that
both Itk and Btk are intolerant kinases, and mutation of the
gatekeeper residue to methionine, but not isoleucine, activates
these Tec kinases in the absence of the amino-terminal regulatory
domains that normally activate kinase activity.
In addition to measuring the initial velocity associated with
peptide substrate phosphorylation, we can exploit the correlation
between activation loop phosphorylation and activity for these
enzymes. The activity of the wild-type and variant Itk and Btk
enzymes correlates with the level of phosphorylation on the
activation loop tyrosine (Y551 in Btk and Y511 in Itk). Phos-
phorylation on Y551 is observed for bacterially expressed Btk
kinase domains in the absence of incubation with ATP, with the
Btk T474M mutant showing maximal Y551 phosphorylation
(Figure 3c). Incubation of the purified Btk kinase domains with
ATP shows that the Btk T474M mutant autophosphorylates
itself on Y551 more efficiently than wild-type Btk (Figure 3c).
Unlike that of Btk, phosphorylation of Itk Y511 is detected only
after incubation of the purified Itk kinases withATP (Figure 3d).
The Itk F434M mutant shows greater phosphorylation on Y511
than wild-type Itk (Figure 3d). Given the results described above
that show the L432I mutation activates Itk, we tested whether
this mutation would further activate the Itk gatekeeper F434M
mutant. Indeed it does; the Itk L432I/F434M double mutant
within the isolated kinase domain of Itk shows greater phosphor-
ylation on Y511 compared to the Itk F434Mmutant (Figure 3d)
and brings about a 1.5-fold increase in activity toward a peptide
substrate over that of Itk F434M (Figure 3b and Table 1). As
suggested above for the rescue of the intolerant Itk kinase, it is
possible that the Itk L432I mutation promotes the assembly of
the regulatory spine within Itk, leading to the more active kinase.
While there is a direct correlation between the level of
phosphorylation on the activation loop and activity of Itk and
Btk, phosphorylation on the activation loop (Itk Y511 or Btk
Y551) has been previously shown to activate Itk and Btk (17).
While the Itk kinase domains purified from bacteria are uni-
formly unphosphorylated on Y511, the Btk kinase domain
mutants exhibit differential phosphorylation on the activation
loop Y551 (Figure 3c). To ensure that the activity measurements
of the Btk kinase domain mutants (using a peptide substrate)
are not skewed because of this differential phosphorylation on
Y551, the Btk kinase domain mutants were preincubated for
various times with ATP to normalize the pY551 levels, and these
Table 1
Vi/[enzyme]
a (min-1)
Full-Length Itk
wild-type Itk 0.81( 0.04
Itk K390R 0.001( 0.00
Itk F434A 0.003( 0.00
Itk F434G 0.19( 0.04
Itk L432I/F434A 0.60( 0.06
Itk C431V/F434A 0.009( 0.007
Itk L375V/F434A 0.021( 0.018
Itk H377V/F434A 0.030( 0.029
Itk Isolated Kinase Domain
background 0.004 ( 0.0005
wild-type Itk 0.004 ( 0.0003
Itk F434T 0.003 ( 0.0002
Itk F434I 0.005 ( 0.0001
Itk F434M 0.008 ( 0.0003
Itk L432I/F434M 0.010( 0.0006
Btk Isolated Kinase Domain
Vi/[enzyme] (min
-1)
without pY551
level normalization
pY551 level
normalized
background 0.001( 0.000 0.001( 0.001
wild-type Btk 0.09( 0.001 0.10( 0.001
Btk T474A 0.06( 0.001 0.03( 0.015
Btk T474M 0.56( 0.060 0.53 ( 0.084
Btk T474I 0.06 ( 0.000 0.12( 0.008
aActivity measurements were taken at room temperature using 5 μCi of
[32P]ATP and Peptide B (aminohexanoyl biotin-EQEDEPEGIYGVLF-
NH2) as a substrate in kinase assay buffer [50 mM Hepes (pH 7.0), 10 mM
MgCl2, 1 mM DTT, 1 mg/mL BSA, and 1 mM Pefabloc] as described
previously (10).
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pY551-normalized enzymes were then tested for kinase activity
using a peptide substrate as described above. As shown in
Figure 3, the relative activities of the Btk kinases with normalized
levels of pY551 (Figure 3e,f and Table 1) are similar to that of the
Btk kinases prior to pY551 level normalization (Figure 3c and
Table 1). Hence, the observed changes in activity due to the
gatekeeper mutations are reflective of the changes in the intrinsic
kinase activity of Btk.
We note that the activity of Itk (wild type and mutants) is
consistently lower than that of Btk (Table 1). One significant
difference already noted is the identity of the gatekeeper residue.
Despite the fact that the less active Itk contains the bulkier
hydrophobic gatekeeper, we mutated Itk F434 to threonine,
the corresponding gatekeeper residue in Btk, to assess whether
this difference is responsible for the observed activity differences.
This mutation, F434T, has no effect on Itk kinase activity
(Figure 3b,d and, Table 1), so the differences in the basal activity
of the wild-type isolated kinase domains of Itk and Btk cannot be
ascribed to the difference in the identity of the gatekeeper residue.
Future work will explore the basis for the observed differences in
activity among the Tec family kinases.
DISCUSSION
The regulatory spine is a key modulator of kinase activity
(18, 19), and our recent work identified an extended spine
structure that controls the activity of the Tec family kinases (20).
The gatekeeper residue sits at the edge of the regulatory spine
structure, so it is logical that, for Itk, the loss of the large
phenylalanine gatekeeper by mutation to alanine inactivates Itk
(Figure 1c). The crystal structure of Itk (8) shows that the second-
site activating mutation, L432I, is adjacent to the gatekeeper
residue F434 and the regulatory spine residue M409 (Figure 4).
Models of the Itk kinase domain with the F434A single mutation
FIGURE 2: ItkL432I/F434Adoublemutation that rescues the activity of the Itk gatekeeperF434Amutation. (a) Location of potential second-site
activatingmutations within theN-terminal lobe of the Itk kinase domain. The crystal structure of the Itk kinase domain (brown cartoon) with the
β2, β3, and β5 strands of the N-terminal lobe is shown. The four potential activating sites (L375, H377, C431, and L432) are shown as blue sticks,
and the gatekeeper (F434) residue is colored orange (sticks and spheres). (b) The L432I mutation rescues the activity of the F434A gatekeeper
mutation in Itk.TheL375V,H377V,C431V, andL432Imutationsweremade in the context of full-length ItkF434A, and thedoublemutantswere
tested for kinase activity as described in Experimental Procedures. The Itk L432I/F434A double mutation recovers the activity of the Itk F434A
mutant. (c-e) Kinetic parameters of the full-length Itk L432I/F434Adoublemutant. Substrate (peptide B orATP) curves ofwild-type full-length
Itk [FLWT (2)] or Itk L432I/F434A doublemutant [FLL432I/F434A (0)] were fit to theMichaelis-Menten equation usingGraphFit to obtain
the kinetic parameters reported in panel e. The values for full-length wild-type Itk have been reported previously (10).
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and the L432I/F434A double mutation show that the substitu-
tion of a β-branched Ile residue at position 432 likely compensates
for the loss of hydrophobicity of the F434A mutation favoring
assembly of the regulatory spine within Itk (Figure 4a-c). It is
generally accepted that β-branched residues are preferred over
non-β-branched residues within β-sheets (29, 30), so it is also
possible that the β-branched isoleucine in the Itk L432I/F434A
double mutant simply stabilizes the overall fold of the kinase. It
should be noted, however, that we introduced β-branched residues
at a number of different locations within the amino-terminal lobe
of the kinase (all on β-strand structures), and none of these other
substitutions rescued the activity of the Itk F434A mutant
(Figure 2a). Thus, while introduction of β-branched residues
might increase the overall stability of the β-sheet, the fact that
the L432I mutation is the only one among all the β-branched
residues that rescued the activity of Itk points to its proximity to
FIGURE 3: Mutation of the gatekeeper residue tomethionine activates Tec kinases in the absence of theN-terminal regulatory domains. (a and b)
The gatekeeper residuesof Itk andBtkweremutated toalanine,methionine, isoleucine, and threonine in the contextof the isolatedkinasedomains
and tested for in vitro kinase activity as described in Experimental Procedures. Mutation of the Itk and Btk gatekeeper residues, F434 and T474,
respectively, tomethionine activates the isolatedkinasedomains of Itk andBtk.The inset inpanel a shows theBtkT474Amutant is approximately
half as active as the wild-type Btk kinase domain. (c and d) Activity of the Tec kinase gatekeeper mutations correlates with the level of
phosphorylation on the activation loopof the kinase. The purified 250 nMkinase domain ofwild-type Btk, T474A,T474I, orT474Morwild-type
Itk, F434T, F434I, F434M, or L432I/F434Mwas incubated in a kinase assay buffer at room temperature for 1 h without or with ATP, separated
by SDS-PAGE, transferred onto a polyvinylidene difluoride (PVDF) membrane, and probed with either an anti-Btk pY551 (also used to detect
Itk pY511) or anti-His antibody. The exposure time for the Itk panel is 10 times longer than that for the Btk panel. (e) Normalization of
phosphorylation level onBtkY551.Thepurified250nMkinasedomainofwild-typeBtk,T474A,T474I, orT474MwaspreincubatedwithATP in
a kinase assay buffer as described in Experimental Procedures. The Btk enzymes were then probedwith an anti-Btk pY551 and anti-His antibody
as described above. (f) The Btk kinase domain enzymes in panel e that were normalized for phosphorylation on Btk Y551 were tested for in vitro
kinase activity as described above.
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the regulatory spine as a key factor in its ability to act as a second-
site activating mutation.
Interestingly, there are differences in regulation evenwithin the
Tec family kinases. The isolated wild-type Btk kinase domain is
significantly more active than the isolated Itk kinase domain
(Figure 3a,b and Table 1). Swapping the gatekeeper residue in Itk
to that of Btk did not generate a more active Itk enzyme
(Figure 3b,d and Table 1). One possibility for the observed
difference in activity between Itk and Btk might be related to
the nature of the residue at the activating second site identified in
this work. Comparison of the Itk and Btk kinase domain
sequences shows that wild-type Btk contains a β-branched
residue (isoleucine) at the position corresponding to L432 in
Itk (Figure 1a). Mutation of L432 to isoleucine in Itk increased
catalytic activity, so the isoleucine already present at this site in
Btk might lead to the higher basal activity observed for the wild-
type Btk kinase domain. However, while the Itk L432I mutation
is activating, this substitution did not increase Itk activity to the
level of Btk and its variants (Figure 3a,b and Table 1), so
additional parameters must also affect the relative activities of
each enzyme.
The noncatalytic regulatory domains of the Tec kinases serve a
positive role in controlling kinase activity. Disconnecting the
regulatory region from the catalytic kinase domain (either by
mutation of W355 in the Itk SH2--kinase linker region or by
truncation of the enzyme to yield the isolated, independent kinase
domain) results in an enzyme with very poor catalytic activ-
ity (9, 10, 16). In our work, we have found that mutation of
residues that surround the regulatory spines of Itk andBtk results
in increased catalytic activity of the independent kinase domains.
In particular, the Itk F434M and Btk T474M mutations in the
context of the free kinase domain are significantly activating and
partially overcome the requirement for the SH2-kinase linker
(Figure 3 and Table 1). These findings suggest that for the wild-
type kinase domains of the Tec kinases, the conformational
preference of the regulatory spine is the inactive, disassembled
state and the active, assembled conformation is energetically
disfavored. The active conformation is stabilized only upon
additional interactions between the kinase domain and the
amino-terminal regulatory region (20). Gain-of-function muta-
tions for the Tec kinases have to date been elusive, andwe suggest
that the Itk F434M and Btk T474Mmutants might find utility as
a research reagent.
In addition to the N-terminal regulatory domains, phosphor-
ylation of the activation loop has also been shown to activate
kinases (17). For Itk, activation by phosphorylation on the acti-
vation loop is completely dependent on the presence of the
SH2-kinase linker region. Indeed, while phosphorylation on
the activation loop has been shown to activate full-length Itk or
deletion constructs of Itk kinase containing the SH2-kinase
linker region (10, 17), the isolated kinase domain of Itk (without
the SH2-kinase linker) exhibits poor catalytic activity evenwhen
completely phosphorylated on the activation loop (Figure 1 of
ref 8). Additionally, activity assays that directly compare two
equally phosphorylated fragments of Itk that differ only with
respect to the presence of the linker region indicate that the
FIGURE 4: Itk L432I mutation that likely restores the regulatory spine in the Itk F434A mutant. The crystal structure of the Itk kinase domain
[ProteinDataBankentry 3MIY (gray cartoon)] is shownat the leftwith the locationof the regulatory spine residue (M409), the gatekeeper residue
(F434), and the site of the secondary activating mutation (L432) (cyan sticks and dots) indicated. The boxed region is expanded in panels a-c.
Comparison of the side chain packing within (a) wild-type Itk (ProteinData Bank entry 3MIY), (b) a model of the Itk F434A single mutant, and
(c) a model of the Itk L432I/F434A double mutant. The introduction of the β-branched isoleucine residue at position 432 is likely more effective
than the introduction of leucine in compensating for the loss of hydrophobicity of the gatekeeper F434Amutation. The leucine rotamer about χ1
shown inpanel b is unchanged from the Itk crystal structure (ProteinDataBank entry 3MIY) shown inpanel a.While alternative leucine rotamers
might be favored in the F434A single mutant, inspection of the alternative rotamers suggests that none appear to show an increased level of
packing with the residues at positions 434 and 409 in the context of the 3MIY structure compared to that shown in panel b. Kinetic data (see
Table 1) are indicated for each structural model.
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linker-containing fragment of Itk is almost as active as full-length
Itk while the smaller fragment that contains only the kinase
domain of Itk (lacking the SH2-kinase linker) exhibits poor
activity regardless of phosphorylation state (10). These data
suggest that the poor activity of the isolated kinase domain of
Itk is not due to the lack of phosphorylation on the activation
loop; rather, it is the SH2-kinase linker region that is essential
for the assembly of the regulatory spine within the isolated kinase
domain of Itk (10, 20). This is also consistent with the observation
that the Itk regulatory spine is not assembled in the crystal
structures of the phosphorylated Itk kinase domain lacking the
linker region (8, 20). Thus, in the context of wild-type full-length
Itk, phosphorylation of the activation loop certainly drives the
conformational equilibrium of the regulatory spine to that of the
assembled state, but the SH2-kinase linker region is an equal if not
more critical component of the activatingmachinery of this kinase.
Identification of legitimate in vivo substrates of kinases has
been challenging (31). The gain-of-function mutant described
above may be one approach to advancing our understanding of
Tec family kinase signaling. Another approach that has been
developed and used widely for the identification of protein kinase
substrates involves mutation of the gatekeeper residue to a
residue with a small side chain (32). Mutation of the gatekeeper
residue to alanine or glycine creates a “hole” within the kinase
domain active site that can accommodate larger modified ATP
analogues or tailored inhibitors that can be used to identify
kinase specific substrates in vivo. In this work, we have shown
that Itk is intolerant to this type of gatekeeper mutation (Itk
F434A is inactive) but can be rescued bymutation at a second site
(L432I). The location of this second-site activating mutation
suggests a role for the kinase regulatory spine; loss of hydro-
phobic packing interactions upon mutation of the gatekeeper
phenylalanine to alaninemight be balanced by favorable contacts
with the isoleucine side chain at position 432. In addition to side
chain packing effects, changes in backbone dynamics and/or
flexibility could also contribute to the observed activating effect
of these mutations. Regardless of the precise mechanism by
which these combinations of mutations promote Itk activity, the
Itk L432I/F434A double mutant is a useful tool for probing Itk
specific signaling.
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SUPPORTING INFORMATION AVAILABLE
Comparison of the CD spectra of the Btk and Itk isolated
kinase domains. Panel a shows the CD spectra of the wild-type
isolated Btk kinase domain superimposed with spectra of the
isolated Btk kinase domain mutants (T474A, T474M, and
T474I). Panel b shows the CD spectra of the wild-type isolated
Itk kinase domain superimposed with spectra of the isolated Itk
kinase domain mutants (F434M, F434I, and F434T single
mutants and L432I/F434M double mutant). This material is
available free of charge via the Internet at http://pubs.acs.org.
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